Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Martin

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|December 5, 2002
No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteersPaul D Martin, John Kemp, Aaron L Dane, et al.
Journal of Clinical Pharmacology|October 5, 2002
No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitorPaul D Martin, Aaron L Dane, Olise M Nwose, et al.
British Journal of Clinical Pharmacology|March 5, 2004
The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptiveSteven G Simonson, Paul D Martin, Mike J Warwick, et al.
Journal of Clinical Pharmacology|July 20, 2005
Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokineticsSteven G Simonson, Paul D Martin, Patrick D Mitchell, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjectsKelvin J Cooper, Paul D Martin, Aaron L Dane, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Effect of itraconazole on the pharmacokinetics of rosuvastatinKelvin J Cooper, Paul D Martin, Aaron L Dane, et al.
European Journal of Clinical Pharmacology|September 22, 2015
Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemiaMerran Macpherson, Bengt Hamrén, Marjet J A M Braamskamp, et al.
Clinical Therapeutics|December 25, 2003
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteersPaul D Martin, Mike J Warwick, Aaron L Dane, et al.
Current Medical Research and Opinion|August 5, 2008
Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemiaTsang-Bin Tzeng, Dennis W Schneck, Bruce K Birmingham, et al.
Clinical Therapeutics|May 24, 2011
Pharmacokinetics and tolerability of vandetanib in Chinese patients with solid, malignant tumors: an open-label, phase I, rising multiple-dose studyLi Zhang, Su Li, Yang Zhang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|December 5, 2002
No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteersPaul D Martin, John Kemp, Aaron L Dane, et al.
Journal of Clinical Pharmacology|October 5, 2002
No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitorPaul D Martin, Aaron L Dane, Olise M Nwose, et al.
British Journal of Clinical Pharmacology|March 5, 2004
The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptiveSteven G Simonson, Paul D Martin, Mike J Warwick, et al.
Journal of Clinical Pharmacology|July 20, 2005
Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokineticsSteven G Simonson, Paul D Martin, Patrick D Mitchell, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjectsKelvin J Cooper, Paul D Martin, Aaron L Dane, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Effect of itraconazole on the pharmacokinetics of rosuvastatinKelvin J Cooper, Paul D Martin, Aaron L Dane, et al.
European Journal of Clinical Pharmacology|September 22, 2015
Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemiaMerran Macpherson, Bengt Hamrén, Marjet J A M Braamskamp, et al.
Clinical Therapeutics|December 25, 2003
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteersPaul D Martin, Mike J Warwick, Aaron L Dane, et al.
Current Medical Research and Opinion|August 5, 2008
Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemiaTsang-Bin Tzeng, Dennis W Schneck, Bruce K Birmingham, et al.
Clinical Therapeutics|May 24, 2011
Pharmacokinetics and tolerability of vandetanib in Chinese patients with solid, malignant tumors: an open-label, phase I, rising multiple-dose studyLi Zhang, Su Li, Yang Zhang, et al.
Pageof 3